AETERNUM HEALTH, INC.
AETERNUM HEALTH, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||
Assets Current | ||||||||||||||||
Cash | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Prepaid Expense Current | - | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | |||||
Accounts And Other Receivables Net Current | - | - | - | - | - | - | - | 0 | 0 | - | - | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Assets Noncurrent | ||||||||||||||||
Intangible Assets Net Excluding Goodwill | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Liabilities And Stockhold… | ||||||||||||||||
Liabilities Current | ||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Stockholders Equity | ||||||||||||||||
Common Stock Value | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -2 | -2 | -2 | |||||
Stockholders Equity | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | -1 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 250 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 52 | 49 | 49 | 49 | 49 | 48 | 48 | 48 | 48 | 48 | 47 | |||||
Shares Outstanding | 52 | 49 | 49 | 49 | 49 | 48 | 48 | 48 | 48 | 48 | 47 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | -23.81% | 23.81% | - | - | - | - | - | - | - | - | - | - |
| 2026 | -4.55% | -9.09% | 13.64% | -28.57% | -20.00% | 14.29% | 5.61% | 0.00% | -54.55% | -6.45% | -38.71% | -35.48% |
| 2025 | - | - | - | - | - | - | 122.22% | 48.61% | 19.44% | 0.00% | -1.00% | 15.00% |
| 2024 | -34.48% | -34.48% | -72.41% | 25.00% | 25.00% | -12.50% | 12.86% | -14.29% | -42.86% | 11.11% | 11.11% | -2.78% |
| 2023 | - | - | - | - | - | - | - | - | - | -9.38% | -40.62% | -40.62% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | ||||||||||||||||
| Current Ratio | 0.05 | 0.05 | 0.07 | 0.15 | 0.20 | 0.08 | 0.10 | 0.40 | 0.69 | 1.07 | 1.49 | |||||
| Quick Ratio | 0.02 | 0.01 | 0.05 | 0.13 | 0.18 | 0.02 | 0.05 | 0.37 | 0.67 | 1.03 | 1.43 | |||||
| Working Capital | -1.16M | -1.08M | -980.94K | -843.08K | -737.22K | -757.34K | -618.03K | -316.52K | -147.31K | 30.13K | 177.62K | |||||
Leverage & Debt | ||||||||||||||||
| Debt to Equity | -1.04 | -1.03 | -1.04 | -1.08 | -1.11 | -1.04 | -1.05 | -1.16 | -1.27 | -1.33 | -1.56 | |||||
| Interest Coverage TTM | -5.79 | -3.97 | -4.90 | -4.78 | -5.99 | -7.97 | -7.55 | -7.51 | -7.90 | -7.73 | -18.77 | |||||
| Debt Ratio | 28.49 | 37.64 | 26.65 | 13.15 | 10.12 | 26.62 | 22.04 | 7.26 | 4.66 | 3.49 | 2.78 | |||||
Efficiency & Turnover | ||||||||||||||||
| Asset Turnover TTM | 0.32 | 3.39 | 3.12 | 1.34 | 0.92 | 0.28 | 0.08 | 0.04 | 0.06 | 0.06 | 0.05 | |||||
| Days Sales Outstanding TTM | 718.27 | 1.76 | 12.42 | 156.72 | 128.70 | - | 127.54 | - | 46.97 | 34.17 | 30.89 | |||||
| Receivables Turnover TTM | 0.51 | 206.97 | 29.38 | 2.33 | 2.84 | - | 2.86 | - | 7.77 | 10.68 | 11.81 | |||||
Per Share Metrics | ||||||||||||||||
| Diluted EPS TTM | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | - | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | ||||||||||||||||
| Gross Profit Margin TTM | -41.87% | 58.95% | 49.29% | 45.17% | 43.80% | -45.12% | -201.89% | -181.93% | -174.03% | -107.66% | -54.78% | |||||
| Operating Profit Margin TTM | -997.52% | -132.22% | -220.77% | -209.57% | -293.60% | -1,137.90% | -2,404.92% | -2,979.30% | -2,053.43% | -1,347.62% | -1,022.50% | |||||
| Net Profit Margin TTM | -1,169.81% | -165.52% | -265.86% | -232.28% | -321.09% | -1,210.04% | -2,521.21% | -3,375.65% | -2,374.76% | -2,424.85% | -1,893.40% | |||||
Growth Metrics | ||||||||||||||||
| Net Revenue Growth (1Y) | -82.26% | 187.83% | 828.38% | 1,108.06% | 1,097.08% | 164.93% | -16.20% | -11.99% | -1.25% | 179.68% | 870.65% | |||||
| Net Income Growth (1Y) | -35.37% | -60.63% | -2.10% | -16.87% | 61.85% | 32.21% | 11.59% | 37.17% | -78.46% | -66.62% | -73.28% | |||||
| EPS Growth (1Y) | -37.56% | -61.08% | -3.52% | -18.65% | 61.41% | 30.32% | 9.19% | 34.31% | -79.10% | -69.11% | -75.09% | |||||
Calculated Values | ||||||||||||||||
| Free Cash Flow TTM | -40.84K | -2.96K | 34.50K | -154.12K | -235.59K | -495.65K | -617.09K | -586.05K | -671.90K | -424.10K | -327.90K | |||||
| Net Debt | -19.16K | -15.37K | -53.88K | -23.26K | 0.00 | -18.33K | -19.38K | -177.09K | -278.10K | -414.08K | 627.33K | |||||
Per-Share and Margin | ||||||||||||||||
| EPS TTM | ||||||||||||||||
| Adjusted EPS TTM | ||||||||||||||||
| Cash Flow Per Share TTM | ||||||||||||||||
| Pretax Margin TTM | ||||||||||||||||
| Stock Comp to Revenue TTM | ||||||||||||||||
Turnover Ratios and Averages | ||||||||||||||||
| Average Assets | ||||||||||||||||
| Average Equity | ||||||||||||||||
| Average Inventory | ||||||||||||||||
| Average Receivables | ||||||||||||||||
| Average Accounts Payables | ||||||||||||||||
| Inventory Turnover TTM | ||||||||||||||||
| Payables Turnover TTM | ||||||||||||||||
| Days Inventory Outstanding TTM | ||||||||||||||||
| Days Payables Outstanding TTM | ||||||||||||||||
| Cash Conversion Cycle TTM | ||||||||||||||||
| Working Capital to Revenue | ||||||||||||||||
| Deferred Revenue to Revenue | ||||||||||||||||
Growth Rates | ||||||||||||||||
| Total Assets Growth (1Y) | ||||||||||||||||
| Total Assets Growth (3Y) | ||||||||||||||||
| Total Assets Growth (5Y) | ||||||||||||||||
| Dividends Paid Growth (1Y) | ||||||||||||||||
| Dividends Paid Growth (3Y) | ||||||||||||||||
| Dividends Paid Growth (5Y) | ||||||||||||||||
| EPS Growth (3Y) | ||||||||||||||||
| EPS Growth (5Y) | ||||||||||||||||
| Net Income Growth (3Y) | ||||||||||||||||
| Net Income Growth (5Y) | ||||||||||||||||
| Net Profit Margin Growth (1Y) | ||||||||||||||||
| Net Profit Margin Growth (3Y) | ||||||||||||||||
| Net Profit Margin Growth (5Y) | ||||||||||||||||
| Net Revenue Growth (3Y) | ||||||||||||||||
| Net Revenue Growth (5Y) | ||||||||||||||||
| Deferred Revenue Growth (1Y) | ||||||||||||||||
| Retained Earnings Growth (1Y) | ||||||||||||||||
Credit, Liquidity, Returns, Payout | ||||||||||||||||
| Cash Ratio | ||||||||||||||||
| Net Working Capital | ||||||||||||||||
| Debt to EBITDA TTM | ||||||||||||||||
| Net Debt to EBITDA TTM | ||||||||||||||||
| Net Debt to Equity | ||||||||||||||||
| Altman A | ||||||||||||||||
| Altman B | ||||||||||||||||
| Altman C | ||||||||||||||||
| Altman D | ||||||||||||||||
| Altman E | ||||||||||||||||
| Altman Z-Score | ||||||||||||||||
| ROA TTM | ||||||||||||||||
| ROE TTM | ||||||||||||||||
| NOPAT TTM | ||||||||||||||||
| ROIC TTM | ||||||||||||||||
| Effective Tax Rate TTM | ||||||||||||||||
| Payout Ratio TTM | ||||||||||||||||
| Dilution Ratio | ||||||||||||||||
| Retained Earnings to Equity | ||||||||||||||||
| Treasury Stock to Equity | ||||||||||||||||
| Treasury Stock Change (1Y) | ||||||||||||||||
| Accrued to Current Liabilities | ||||||||||||||||
Valuation Ratios | ||||||||||||||||
| P/CF TTM | ||||||||||||||||
| Dividend Yield TTM | ||||||||||||||||
| Free Cash Flow Yield TTM | ||||||||||||||||
| EV EBITDA TTM | ||||||||||||||||
| EV EBIT TTM | ||||||||||||||||
| Stock Compensation TTM | ||||||||||||||||
| Adjusted Net Income TTM | ||||||||||||||||
| Billings TTM | ||||||||||||||||
| Total Debt | ||||||||||||||||
| Invested Capital | ||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
AETERNUM HEALTH, INC. (AETN) — SEC Financial Statements & Analysis
AETERNUM HEALTH, INC. (AETN) is a miscellaneous electrical machinery, equipment & supplies company, incorporated in DE. AETERNUM HEALTH, INC. trades on OTC as: AETN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), AETERNUM HEALTH, INC. reported a -82.26% year-over-year revenue growth, a Gross Profit Margin of -41.87% (TTM), a Debt-to-Equity ratio of -1.04x. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -82.26%
- Gross Profit Margin TTM
- -41.87%
- Debt To Equity
- -1.04x
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is AETERNUM HEALTH, INC. in?
AETERNUM HEALTH, INC. (AETN) operates in the Miscellaneous Electrical Machinery, Equipment & Supplies industry.
What exchange does AETN trade on?
AETERNUM HEALTH, INC. (AETN) trades on the OTC.
Where is AETERNUM HEALTH, INC. incorporated?
AETERNUM HEALTH, INC. is incorporated in DE.